Paradigm Biopharmaceuticals | PAR - Operating Expenses

Stock Price
0.17
Daily Change
-0.01 -2.86%
Monthly
-24.44%
Yearly
-48.48%
Q2 Forecast
0.18

Paradigm Biopharmaceuticals reported AUD21.85M in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Avita Medical AUD 28.02M 1.55M Dec/2025
Medical Developments International AUD 21.61M 11.59M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Pacific Edge NZD 25.34M 2.03M Dec/2025
PYC Therapeutics AUD 33.63M 14.33M Dec/2025
Telix Pharmaceuticals AUD 405.4M 26.29M Dec/2025